article Open AccessTop 1% cited
2019 Update of the Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA–EDTA) recommendations for the management of lupus nephritis
Annals of the Rheumatic Diseases · 2020 · Vol. 79(6) · pp. 713–723
Antonis Fanouriakis(General Hospital Asklepieio Voulas)Myrto Kostopoulou(General Hospital of Athens G. Genimatas)Kim Cheema(University of Cambridge)Hans‐Joachim Anders(LMU Klinikum)Martin Aringer(University Hospital Carl Gustav Carus)Ingeborg M. Bajema(Leiden University Medical Center)John Boletis(National and Kapodistrian University of Athens)Eleni Frangou(Limassol General Hospital)Frédéric Houssiau(Cliniques Universitaires Saint-Luc)Jane Hollis(Addenbrooke's Hospital)A. Karras(Assistance Publique – Hôpitaux de Paris)Francesca MarchioriStephen D. Marks(Great Ormond Street Hospital)Gabriella Moroni(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico)Marta Mosca(University of Pisa)Ioannis Parodis(Karolinska University Hospital)Manuel Praga(Universidad Complutense de Madrid)Matthias Schneider(Heinrich Heine University Düsseldorf)Josef S Smolen(Medical University of Vienna)Vladimı́r Tesař(Charles University)Maria Trachana(Aristotle University of Thessaloniki)Ronald van VollenhovenAlexandre E. VoskuylY K Onno Teng(Leiden University Medical Center)Bernadette van LeewGeorge Βertsias(University Hospital of Heraklion)David Jayne(University of Cambridge)Dimitrios T. Boumpas✉(Biomedical Research Foundation of the Academy of Athens)
Systemic Lupus Erythematosus ResearchRenal Diseases and GlomerulopathiesInflammatory Bowel DiseaseMedicineLupus nephritisRituximabHydroxychloroquineProteinuriaInternal medicineMycophenolic acidAzathioprineUrologyNephrotic syndrome
MeSH terms
AzathioprineDrug Therapy, CombinationEuropeGlomerular Filtration RateGlucocorticoidsHumansHydroxychloroquineImmunosuppressive AgentsKidney Failure, ChronicLupus NephritisMycophenolic AcidProteinuriaSocieties, MedicalAntirheumatic AgentsCalcineurin Inhibitors
Funding
- Sanofi
- European League Against Rheumatism
- Genentech
Citations
788
FWCI
88.79
field-weighted impact
References
131
Percentile
100%
vs. same field & year
Citations per year
Cited by
EULAR recommendations for the management of systemic lupus erythematosus: 2023 update
Annals of the Rheumatic Diseases · 2023 · 803 citations
References
Influence of race/ethnicity on response to lupus nephritis treatment: the ALMS study
Lara D. Veeken · 2009 · 352 citations
Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis
Annals of the Rheumatic Diseases · 2012 · 1,018 citations
The classification of glomerulonephritis in systemic lupus erythematosus revisited
Kidney International · 2004 · 1,623 citations
The frequency and outcome of lupus nephritis: results from an international inception cohort study
Lara D. Veeken · 2015 · 613 citations
EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome
Annals of the Rheumatic Diseases · 2016 · 875 citations
Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy (2016 Revision)
Ophthalmology · 2016 · 1,143 citations
2016 European Guidelines on cardiovascular disease prevention in clinical practice
European Heart Journal · 2016 · 6,439 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.